{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:11:06Z","timestamp":1753891866160,"version":"3.41.2"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Lymphoblastic lymphoma (LBL) is a rare tumor that accounts for approximately 2-4% of all non-Hodgkin lymphomas, and less than 20% of LBLs are derived from B cells. B- Lymphoblastic lymphoma (B-LBL) often presents as bone marrow and peripheral blood lesions, and is very rare to present as a seller mass. We report a case of sellar B lymphoblastic lymphoma mimicking pituitary apoplexy, and review its diagnosis and treatment process, combined with the literature to deepen the understanding of sellar tumors.<\/jats:p>","DOI":"10.3389\/fonc.2023.1087232","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T09:35:50Z","timestamp":1675762550000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Sellar B lymphoblastic lymphoma mimics pituitary apoplexy with newly discovered gene mutations in TP53 and PAX5: A case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Yi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ce","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feirong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panpan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xintao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11912-021-01168-x","article-title":"Lymphoblastic lymphoma: a concise review","volume":"24","author":"Intermesoli","year":"2022","journal-title":"Curr Oncol Rep"},{"key":"B3","article-title":"B lymphoblastic leukaemia\/lymphoma, not otherwise specified","author":"Borowitz","year":"2008","journal-title":"Who Classification Tumours Haematopoietic Lymphoid Tissues"},{"key":"B4","article-title":"Primary lymphoma of the pituitary stalk presenting as diabetes insipidus and visual deterioration: a case report and literature review","volume":"11","author":"Yang","year":"2018","journal-title":"Int J Clin Exp Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/01.ten.0000139004.32317.4c","article-title":"Primary pituitary lymphoma","volume":"14","author":"Gola","year":"2004","journal-title":"Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08541.x","article-title":"Clinical presentation, evolution, and prognosis of precursor b-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951","volume":"152","author":"Ducassou","year":"2011","journal-title":"Br J Haematol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26363","article-title":"Genomic characterization of pediatric b-lymphoblastic lymphoma and b-lymphoblastic leukemia using formalin-fixed tissues","volume":"64","author":"Meyer","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.08.028","article-title":"Putting p53 in context","volume":"170","author":"Kastenhuber","year":"2017","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000002388","article-title":"Impact of single or combined genomic alterations of TP53, MYC, and BCL2 on survival of patients with diffuse Large b-cell lymphomas: A retrospective cohort study","volume":"94","author":"Schiefer","year":"2015","journal-title":"Medicine"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-129783","article-title":"Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large b-cell lymphoma: an international collaborative study","volume":"112","author":"Young","year":"2008","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2008.06.022","article-title":"TP53 mutations predict for poor survival in de novo diffuse large b-cell lymphoma of germinal center subtype","volume":"33","author":"Zainuddin","year":"2009","journal-title":"Leukemia Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07739.x","article-title":"The significance of TP53 in lymphoid malignancies: mutation prevalence, regulation, prognostic impact and potential as a therapeutic target","volume":"146","author":"Cheung","year":"2009","journal-title":"Br J haematol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.007526","article-title":"Frequency and clinical relevance of DNA microsatellite alterations of the CDKN2A\/B, ATM and p53 gene loci: a comparison between pediatric precursor T-cell lymphoblastic lymphoma and T-cell lymphoblastic leukemia","volume":"95","author":"Krieger","year":"2010","journal-title":"Haematologica"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0b013e3180ca8a49","article-title":"Diagnostic uses of Pax5 immunohistochemistry","volume":"14","author":"Feldman","year":"2007","journal-title":"Adv Anatom Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.7860\/jcdr\/2016\/21476.8352","article-title":"Diagnostic utility of PAX5 in Hodgkin and non-Hodgkin lymphoma: A study from northern India","volume":"10","author":"Johri","year":"2016","journal-title":"J Clin Diagn Res JCDR"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1172\/jci30842","article-title":"B cell activator PAX5 promotes lymphomagenesis through stimulation of b cell receptor signaling","volume":"117","author":"Cozma","year":"2007","journal-title":"J Clin Invest"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.140","article-title":"Differential PAX5 levels promote malignant b-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1","volume":"30","author":"Teo","year":"2016","journal-title":"Leukemia"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.135","article-title":"PAX5 mutations occur frequently in adult b-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study","volume":"23","author":"Familiades","year":"2009","journal-title":"Leukemia"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.145102","article-title":"Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma","volume":"101","author":"Camus","year":"2016","journal-title":"Haematologica"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.Mcr-13-0350","article-title":"The molecular balancing act of p16(INK4a) in cancer and aging","volume":"12","author":"LaPak","year":"2014","journal-title":"Mol Cancer Res MCR"},{"key":"B21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.mrfmmm.2004.08.021","article-title":"INK4a\/ARF: a multifunctional tumor suppressor locus","volume":"576","author":"Sharpless","year":"2005","journal-title":"Mutat Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1087232\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T09:35:56Z","timestamp":1675762556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1087232\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":21,"alternative-id":["10.3389\/fonc.2023.1087232"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1087232","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2023,2,7]]},"article-number":"1087232"}}